Fred Hutch selected Dr. Paul Nghiem's article published in JCO "Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy." to be covered in the March 2019 issue of Science Spotlight, a monthly online publication highlighting scientific work performed…
MCC posters presented by Nghiem Lab Members at this year's SID meeting in Atlanta. - Christopher Lewis
Dr. Nghiem was appointed to the Michael W. Piepkorn Endowed Chair in Dermatology, effective October 1, 2011. Dr. Nghiem is currently Associate Professor of Medicine and Adjunct Associate Professor of Pathology, as well as an Affiliate Investigator in the Clinical Research…
Rapamycin and nutrient signaling are profiled in a review with Aly Shamji and Stuart Schreiber. [pdf]